Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [18F] FDG-PET imaging combined with proteomic approaches
Tetyana Tegnebratt(Karolinska University Hospital), Sharon Stone‐Elander(Karolinska University Hospital)
Cited by 11